Complications and outcomes of posterior fossa decompression with duraplasty versus without duraplasty for pediatric patients with Chiari malformation type I and syringomyelia: a study from the Park-Reeves Syringomyelia Research Consortium

Hassan S.A. Akbari; Alexander T. Yahanda; Laurie L. Ackerman; P. David Adelson; Raheel Ahmed; Gregory W. Albert; Philipp R. Aldana; Tord D. Alden; Richard C.E. Anderson; David F. Bauer; Tammy Bethel-Anderson; Karin Bierbrauer; Douglas L. Brockmeyer; Joshua J. Chern; Daniel E. Couture; David J. Daniels; Brian J. Dlouhy; Susan R. Durham; Richard G. Ellenbogen; Ramin Eskandari; Herbert E. Fuchs; Gerald A. Grant; Patrick C. Graupman; Stephanie Greene; Jeffrey P. Greenfield; Naina L. Gross; Daniel J. Guillaume; Todd C. Hankinson; Gregory G. Heuer; Mark Iantosca; Bermans J. Iskandar; Eric M. Jackson; George I. Jallo; James M. Johnston; Bruce A. Kaufman; Robert F. Keating; Nicklaus R. Khan; Mark D. Krieger; Jeffrey R. Leonard; Cormac O. Maher; Francesco T. Mangano; J. Gordon McComb; Sean D. McEvoy; Thanda Meehan; Arnold H. Menezes; Michael S. Muhlbauer; Brent R. O'Neill; Greg Olavarria; John Ragheb; Nathan R. Selden; Manish N. Shah; Chevis N. Shannon; Joshua S. Shimony; Matthew D. Smyth; Scellig S.D. Stone; Jennifer M. Strahle; Mandeep S. Tamber; James C. Torner; Gerald F. Tuite; Elizabeth C. Tyler-Kabara; Scott D. Wait; John C. Wellons; William E. Whitehead; Tae Sung Park; David D. Limbrick

doi:10.3171/2022.2.PEDS21446

Complications and outcomes of posterior fossa decompression with duraplasty versus without duraplasty for pediatric patients with Chiari malformation type I and syringomyelia: a study from the Park-Reeves Syringomyelia Research Consortium

Hassan S.A. Akbari, Alexander T. Yahanda, Laurie L. Ackerman, P. David Adelson, Raheel Ahmed, Gregory W. Albert, Philipp R. Aldana, Tord D. Alden, Richard C.E. Anderson, David F. Bauer, Tammy Bethel-Anderson, Karin Bierbrauer, Douglas L. Brockmeyer, Joshua J. Chern, Daniel E. Couture, David J. Daniels, Brian J. Dlouhy, Susan R. Durham, Richard G. Ellenbogen, Ramin EskandariHerbert E. Fuchs, Gerald A. Grant, Patrick C. Graupman, Stephanie Greene, Jeffrey P. Greenfield, Naina L. Gross, Daniel J. Guillaume, Todd C. Hankinson, Gregory G. Heuer, Mark Iantosca, Bermans J. Iskandar, Eric M. Jackson, George I. Jallo, James M. Johnston, Bruce A. Kaufman, Robert F. Keating, Nicklaus R. Khan, Mark D. Krieger, Jeffrey R. Leonard, Cormac O. Maher, Francesco T. Mangano, J. Gordon McComb, Sean D. McEvoy, Thanda Meehan, Arnold H. Menezes, Michael S. Muhlbauer, Brent R. O'Neill, Greg Olavarria, John Ragheb, Nathan R. Selden, Manish N. Shah, Chevis N. Shannon, Joshua S. Shimony, Matthew D. Smyth, Scellig S.D. Stone, Jennifer M. Strahle, Mandeep S. Tamber, James C. Torner, Gerald F. Tuite, Elizabeth C. Tyler-Kabara, Scott D. Wait, John C. Wellons, William E. Whitehead, Tae Sung Park, David D. Limbrick

Neurosurgery

Research output: Contribution to journal › Article › peer-review

17 Scopus citations

Abstract

OBJECTIVE The aim of this study was to determine differences in complications and outcomes between posterior fossa decompression with duraplasty (PFDD) and without duraplasty (PFD) for the treatment of pediatric Chiari malformation type I (CM1) and syringomyelia (SM). METHODS The authors used retrospective and prospective components of the Park-Reeves Syringomyelia Research Consortium database to identify pediatric patients with CM1-SM who received PFD or PFDD and had at least 1 year of follow-up data. Preoperative, treatment, and postoperative characteristics were recorded and compared between groups. RESULTS A total of 692 patients met the inclusion criteria for this database study. PFD was performed in 117 (16.9%) and PFDD in 575 (83.1%) patients. The mean age at surgery was 9.86 years, and the mean follow-up time was 2.73 years. There were no significant differences in presenting signs or symptoms between groups, although the preoperative syrinx size was smaller in the PFD group. The PFD group had a shorter mean operating room time (p < 0.0001), fewer patients with > 50 mL of blood loss (p = 0.04), and shorter hospital stays (p = 0.0001). There were 4 intraoperative complications, all within the PFDD group (0.7%, p > 0.99). Patients undergoing PFDD had a 6-month complication rate of 24.3%, compared with 13.7% in the PFD group (p = 0.01). There were no differences between groups for postoperative complications beyond 6 months (p = 0.33). PFD patients were more likely to require revision surgery (17.9% vs 8.3%, p = 0.002). PFDD was associated with greater improvements in headaches (89.6% vs 80.8%, p = 0.04) and back pain (86.5% vs 59.1%, p = 0.01). There were no differences between groups for improvement in neurological examination findings. PFDD was associated with greater reduction in anteroposterior syrinx size (43.7% vs 26.9%, p = 0.0001) and syrinx length (18.9% vs 5.6%, p = 0.04) compared with PFD. CONCLUSIONS PFD was associated with reduced operative time and blood loss, shorter hospital stays, and fewer postoperative complications within 6 months. However, PFDD was associated with better symptom improvement and reduction in syrinx size and lower rates of revision decompression. The two surgeries have low intraoperative complication rates and comparable complication rates beyond 6 months.

Original language	English (US)
Pages (from-to)	39-51
Number of pages	13
Journal	Journal of Neurosurgery: Pediatrics
Volume	30
Issue number	1
DOIs	https://doi.org/10.3171/2022.2.PEDS21446
State	Published - Jul 2022

Bibliographical note

Funding Information:
This publication was made possible through the support of Sam and Betsy Reeves, the Spears and O’Keefe families, and the many other contributors to the Park-Reeves Syringomyelia Research Consortium. Support was also provided by the Eunice Kennedy Shriver National Institute of Child Health & Human Development of the National Institutes of Health under award number U54 HD087011 to the Intellectual and Developmental Disabilities Research Center at Washington University. We furthermore appreciate the help of Timothy M. George, MD, and Sanjiv Bhatia, MD, who both contributed to this study but passed away before this manuscript was written. Research reported in this publication was supported by the Park-Reeves Syringomyelia Research Consortium and the National Center for Advancing Translational Sciences of the National Institutes of Health under award number UL1 TR002345. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Additional funding was provided by an American Syringomyelia Alliance Project, Inc. grant.

Publisher Copyright:
© AANS 2022, except where prohibited by US copyright law

Keywords

Chiari malformation
Park-Reeves
duraplasty
posterior fossa decompression
syringomyelia

Publisher link

10.3171/2022.2.PEDS21446

Find It

Find It at U of M Libraries

Fingerprint

Dive into the research topics of 'Complications and outcomes of posterior fossa decompression with duraplasty versus without duraplasty for pediatric patients with Chiari malformation type I and syringomyelia: a study from the Park-Reeves Syringomyelia Research Consortium'. Together they form a unique fingerprint.

Cite this

Akbari, H. S. A., Yahanda, A. T., Ackerman, L. L., Adelson, P. D., Ahmed, R., Albert, G. W., Aldana, P. R., Alden, T. D., Anderson, R. C. E., Bauer, D. F., Bethel-Anderson, T., Bierbrauer, K., Brockmeyer, D. L., Chern, J. J., Couture, D. E., Daniels, D. J., Dlouhy, B. J., Durham, S. R., Ellenbogen, R. G., ... Limbrick, D. D. (2022). Complications and outcomes of posterior fossa decompression with duraplasty versus without duraplasty for pediatric patients with Chiari malformation type I and syringomyelia: a study from the Park-Reeves Syringomyelia Research Consortium. Journal of Neurosurgery: Pediatrics, 30(1), 39-51. https://doi.org/10.3171/2022.2.PEDS21446

Complications and outcomes of posterior fossa decompression with duraplasty versus without duraplasty for pediatric patients with Chiari malformation type I and syringomyelia: a study from the Park-Reeves Syringomyelia Research Consortium. / Akbari, Hassan S.A.; Yahanda, Alexander T.; Ackerman, Laurie L. et al.
In: Journal of Neurosurgery: Pediatrics, Vol. 30, No. 1, 07.2022, p. 39-51.

Research output: Contribution to journal › Article › peer-review

Akbari, HSA, Yahanda, AT, Ackerman, LL, Adelson, PD, Ahmed, R, Albert, GW, Aldana, PR, Alden, TD, Anderson, RCE, Bauer, DF, Bethel-Anderson, T, Bierbrauer, K, Brockmeyer, DL, Chern, JJ, Couture, DE, Daniels, DJ, Dlouhy, BJ, Durham, SR, Ellenbogen, RG, Eskandari, R, Fuchs, HE, Grant, GA, Graupman, PC, Greene, S, Greenfield, JP, Gross, NL, Guillaume, DJ, Hankinson, TC, Heuer, GG, Iantosca, M, Iskandar, BJ, Jackson, EM, Jallo, GI, Johnston, JM, Kaufman, BA, Keating, RF, Khan, NR, Krieger, MD, Leonard, JR, Maher, CO, Mangano, FT, McComb, JG, McEvoy, SD, Meehan, T, Menezes, AH, Muhlbauer, MS, O'Neill, BR, Olavarria, G, Ragheb, J, Selden, NR, Shah, MN, Shannon, CN, Shimony, JS, Smyth, MD, Stone, SSD, Strahle, JM, Tamber, MS, Torner, JC, Tuite, GF, Tyler-Kabara, EC, Wait, SD, Wellons, JC, Whitehead, WE, Park, TS & Limbrick, DD 2022, 'Complications and outcomes of posterior fossa decompression with duraplasty versus without duraplasty for pediatric patients with Chiari malformation type I and syringomyelia: a study from the Park-Reeves Syringomyelia Research Consortium', Journal of Neurosurgery: Pediatrics, vol. 30, no. 1, pp. 39-51. https://doi.org/10.3171/2022.2.PEDS21446

Akbari HSA, Yahanda AT, Ackerman LL, Adelson PD, Ahmed R, Albert GW et al. Complications and outcomes of posterior fossa decompression with duraplasty versus without duraplasty for pediatric patients with Chiari malformation type I and syringomyelia: a study from the Park-Reeves Syringomyelia Research Consortium. Journal of Neurosurgery: Pediatrics. 2022 Jul;30(1):39-51. doi: 10.3171/2022.2.PEDS21446

Akbari, Hassan S.A. ; Yahanda, Alexander T. ; Ackerman, Laurie L. et al. / Complications and outcomes of posterior fossa decompression with duraplasty versus without duraplasty for pediatric patients with Chiari malformation type I and syringomyelia : a study from the Park-Reeves Syringomyelia Research Consortium. In: Journal of Neurosurgery: Pediatrics. 2022 ; Vol. 30, No. 1. pp. 39-51.

@article{2407c5ae746b435185a47b5cbdcd4f85,

title = "Complications and outcomes of posterior fossa decompression with duraplasty versus without duraplasty for pediatric patients with Chiari malformation type I and syringomyelia: a study from the Park-Reeves Syringomyelia Research Consortium",

abstract = "OBJECTIVE The aim of this study was to determine differences in complications and outcomes between posterior fossa decompression with duraplasty (PFDD) and without duraplasty (PFD) for the treatment of pediatric Chiari malformation type I (CM1) and syringomyelia (SM). METHODS The authors used retrospective and prospective components of the Park-Reeves Syringomyelia Research Consortium database to identify pediatric patients with CM1-SM who received PFD or PFDD and had at least 1 year of follow-up data. Preoperative, treatment, and postoperative characteristics were recorded and compared between groups. RESULTS A total of 692 patients met the inclusion criteria for this database study. PFD was performed in 117 (16.9%) and PFDD in 575 (83.1%) patients. The mean age at surgery was 9.86 years, and the mean follow-up time was 2.73 years. There were no significant differences in presenting signs or symptoms between groups, although the preoperative syrinx size was smaller in the PFD group. The PFD group had a shorter mean operating room time (p < 0.0001), fewer patients with > 50 mL of blood loss (p = 0.04), and shorter hospital stays (p = 0.0001). There were 4 intraoperative complications, all within the PFDD group (0.7%, p > 0.99). Patients undergoing PFDD had a 6-month complication rate of 24.3%, compared with 13.7% in the PFD group (p = 0.01). There were no differences between groups for postoperative complications beyond 6 months (p = 0.33). PFD patients were more likely to require revision surgery (17.9% vs 8.3%, p = 0.002). PFDD was associated with greater improvements in headaches (89.6% vs 80.8%, p = 0.04) and back pain (86.5% vs 59.1%, p = 0.01). There were no differences between groups for improvement in neurological examination findings. PFDD was associated with greater reduction in anteroposterior syrinx size (43.7% vs 26.9%, p = 0.0001) and syrinx length (18.9% vs 5.6%, p = 0.04) compared with PFD. CONCLUSIONS PFD was associated with reduced operative time and blood loss, shorter hospital stays, and fewer postoperative complications within 6 months. However, PFDD was associated with better symptom improvement and reduction in syrinx size and lower rates of revision decompression. The two surgeries have low intraoperative complication rates and comparable complication rates beyond 6 months.",

keywords = "Chiari malformation, Park-Reeves, duraplasty, posterior fossa decompression, syringomyelia",

author = "Akbari, {Hassan S.A.} and Yahanda, {Alexander T.} and Ackerman, {Laurie L.} and Adelson, {P. David} and Raheel Ahmed and Albert, {Gregory W.} and Aldana, {Philipp R.} and Alden, {Tord D.} and Anderson, {Richard C.E.} and Bauer, {David F.} and Tammy Bethel-Anderson and Karin Bierbrauer and Brockmeyer, {Douglas L.} and Chern, {Joshua J.} and Couture, {Daniel E.} and Daniels, {David J.} and Dlouhy, {Brian J.} and Durham, {Susan R.} and Ellenbogen, {Richard G.} and Ramin Eskandari and Fuchs, {Herbert E.} and Grant, {Gerald A.} and Graupman, {Patrick C.} and Stephanie Greene and Greenfield, {Jeffrey P.} and Gross, {Naina L.} and Guillaume, {Daniel J.} and Hankinson, {Todd C.} and Heuer, {Gregory G.} and Mark Iantosca and Iskandar, {Bermans J.} and Jackson, {Eric M.} and Jallo, {George I.} and Johnston, {James M.} and Kaufman, {Bruce A.} and Keating, {Robert F.} and Khan, {Nicklaus R.} and Krieger, {Mark D.} and Leonard, {Jeffrey R.} and Maher, {Cormac O.} and Mangano, {Francesco T.} and McComb, {J. Gordon} and McEvoy, {Sean D.} and Thanda Meehan and Menezes, {Arnold H.} and Muhlbauer, {Michael S.} and O'Neill, {Brent R.} and Greg Olavarria and John Ragheb and Selden, {Nathan R.} and Shah, {Manish N.} and Shannon, {Chevis N.} and Shimony, {Joshua S.} and Smyth, {Matthew D.} and Stone, {Scellig S.D.} and Strahle, {Jennifer M.} and Tamber, {Mandeep S.} and Torner, {James C.} and Tuite, {Gerald F.} and Tyler-Kabara, {Elizabeth C.} and Wait, {Scott D.} and Wellons, {John C.} and Whitehead, {William E.} and Park, {Tae Sung} and Limbrick, {David D.}",

note = "Funding Information: This publication was made possible through the support of Sam and Betsy Reeves, the Spears and O{\textquoteright}Keefe families, and the many other contributors to the Park-Reeves Syringomyelia Research Consortium. Support was also provided by the Eunice Kennedy Shriver National Institute of Child Health & Human Development of the National Institutes of Health under award number U54 HD087011 to the Intellectual and Developmental Disabilities Research Center at Washington University. We furthermore appreciate the help of Timothy M. George, MD, and Sanjiv Bhatia, MD, who both contributed to this study but passed away before this manuscript was written. Research reported in this publication was supported by the Park-Reeves Syringomyelia Research Consortium and the National Center for Advancing Translational Sciences of the National Institutes of Health under award number UL1 TR002345. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Additional funding was provided by an American Syringomyelia Alliance Project, Inc. grant. Publisher Copyright: {\textcopyright} AANS 2022, except where prohibited by US copyright law",

year = "2022",

month = jul,

doi = "10.3171/2022.2.PEDS21446",

language = "English (US)",

volume = "30",

pages = "39--51",

journal = "Journal of Neurosurgery: Pediatrics",

issn = "1933-0707",

publisher = "American Association of Neurological Surgeons",

number = "1",

}

TY - JOUR

T1 - Complications and outcomes of posterior fossa decompression with duraplasty versus without duraplasty for pediatric patients with Chiari malformation type I and syringomyelia

T2 - a study from the Park-Reeves Syringomyelia Research Consortium

AU - Akbari, Hassan S.A.

AU - Yahanda, Alexander T.

AU - Ackerman, Laurie L.

AU - Adelson, P. David

AU - Ahmed, Raheel

AU - Albert, Gregory W.

AU - Aldana, Philipp R.

AU - Alden, Tord D.

AU - Anderson, Richard C.E.

AU - Bauer, David F.

AU - Bethel-Anderson, Tammy

AU - Bierbrauer, Karin

AU - Brockmeyer, Douglas L.

AU - Chern, Joshua J.

AU - Couture, Daniel E.

AU - Daniels, David J.

AU - Dlouhy, Brian J.

AU - Durham, Susan R.

AU - Ellenbogen, Richard G.

AU - Eskandari, Ramin

AU - Fuchs, Herbert E.

AU - Grant, Gerald A.

AU - Graupman, Patrick C.

AU - Greene, Stephanie

AU - Greenfield, Jeffrey P.

AU - Gross, Naina L.

AU - Guillaume, Daniel J.

AU - Hankinson, Todd C.

AU - Heuer, Gregory G.

AU - Iantosca, Mark

AU - Iskandar, Bermans J.

AU - Jackson, Eric M.

AU - Jallo, George I.

AU - Johnston, James M.

AU - Kaufman, Bruce A.

AU - Keating, Robert F.

AU - Khan, Nicklaus R.

AU - Krieger, Mark D.

AU - Leonard, Jeffrey R.

AU - Maher, Cormac O.

AU - Mangano, Francesco T.

AU - McComb, J. Gordon

AU - McEvoy, Sean D.

AU - Meehan, Thanda

AU - Menezes, Arnold H.

AU - Muhlbauer, Michael S.

AU - O'Neill, Brent R.

AU - Olavarria, Greg

AU - Ragheb, John

AU - Selden, Nathan R.

AU - Shah, Manish N.

AU - Shannon, Chevis N.

AU - Shimony, Joshua S.

AU - Smyth, Matthew D.

AU - Stone, Scellig S.D.

AU - Strahle, Jennifer M.

AU - Tamber, Mandeep S.

AU - Torner, James C.

AU - Tuite, Gerald F.

AU - Tyler-Kabara, Elizabeth C.

AU - Wait, Scott D.

AU - Wellons, John C.

AU - Whitehead, William E.

AU - Park, Tae Sung

AU - Limbrick, David D.

N1 - Funding Information: This publication was made possible through the support of Sam and Betsy Reeves, the Spears and O’Keefe families, and the many other contributors to the Park-Reeves Syringomyelia Research Consortium. Support was also provided by the Eunice Kennedy Shriver National Institute of Child Health & Human Development of the National Institutes of Health under award number U54 HD087011 to the Intellectual and Developmental Disabilities Research Center at Washington University. We furthermore appreciate the help of Timothy M. George, MD, and Sanjiv Bhatia, MD, who both contributed to this study but passed away before this manuscript was written. Research reported in this publication was supported by the Park-Reeves Syringomyelia Research Consortium and the National Center for Advancing Translational Sciences of the National Institutes of Health under award number UL1 TR002345. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Additional funding was provided by an American Syringomyelia Alliance Project, Inc. grant. Publisher Copyright: © AANS 2022, except where prohibited by US copyright law

PY - 2022/7

Y1 - 2022/7

N2 - OBJECTIVE The aim of this study was to determine differences in complications and outcomes between posterior fossa decompression with duraplasty (PFDD) and without duraplasty (PFD) for the treatment of pediatric Chiari malformation type I (CM1) and syringomyelia (SM). METHODS The authors used retrospective and prospective components of the Park-Reeves Syringomyelia Research Consortium database to identify pediatric patients with CM1-SM who received PFD or PFDD and had at least 1 year of follow-up data. Preoperative, treatment, and postoperative characteristics were recorded and compared between groups. RESULTS A total of 692 patients met the inclusion criteria for this database study. PFD was performed in 117 (16.9%) and PFDD in 575 (83.1%) patients. The mean age at surgery was 9.86 years, and the mean follow-up time was 2.73 years. There were no significant differences in presenting signs or symptoms between groups, although the preoperative syrinx size was smaller in the PFD group. The PFD group had a shorter mean operating room time (p < 0.0001), fewer patients with > 50 mL of blood loss (p = 0.04), and shorter hospital stays (p = 0.0001). There were 4 intraoperative complications, all within the PFDD group (0.7%, p > 0.99). Patients undergoing PFDD had a 6-month complication rate of 24.3%, compared with 13.7% in the PFD group (p = 0.01). There were no differences between groups for postoperative complications beyond 6 months (p = 0.33). PFD patients were more likely to require revision surgery (17.9% vs 8.3%, p = 0.002). PFDD was associated with greater improvements in headaches (89.6% vs 80.8%, p = 0.04) and back pain (86.5% vs 59.1%, p = 0.01). There were no differences between groups for improvement in neurological examination findings. PFDD was associated with greater reduction in anteroposterior syrinx size (43.7% vs 26.9%, p = 0.0001) and syrinx length (18.9% vs 5.6%, p = 0.04) compared with PFD. CONCLUSIONS PFD was associated with reduced operative time and blood loss, shorter hospital stays, and fewer postoperative complications within 6 months. However, PFDD was associated with better symptom improvement and reduction in syrinx size and lower rates of revision decompression. The two surgeries have low intraoperative complication rates and comparable complication rates beyond 6 months.

AB - OBJECTIVE The aim of this study was to determine differences in complications and outcomes between posterior fossa decompression with duraplasty (PFDD) and without duraplasty (PFD) for the treatment of pediatric Chiari malformation type I (CM1) and syringomyelia (SM). METHODS The authors used retrospective and prospective components of the Park-Reeves Syringomyelia Research Consortium database to identify pediatric patients with CM1-SM who received PFD or PFDD and had at least 1 year of follow-up data. Preoperative, treatment, and postoperative characteristics were recorded and compared between groups. RESULTS A total of 692 patients met the inclusion criteria for this database study. PFD was performed in 117 (16.9%) and PFDD in 575 (83.1%) patients. The mean age at surgery was 9.86 years, and the mean follow-up time was 2.73 years. There were no significant differences in presenting signs or symptoms between groups, although the preoperative syrinx size was smaller in the PFD group. The PFD group had a shorter mean operating room time (p < 0.0001), fewer patients with > 50 mL of blood loss (p = 0.04), and shorter hospital stays (p = 0.0001). There were 4 intraoperative complications, all within the PFDD group (0.7%, p > 0.99). Patients undergoing PFDD had a 6-month complication rate of 24.3%, compared with 13.7% in the PFD group (p = 0.01). There were no differences between groups for postoperative complications beyond 6 months (p = 0.33). PFD patients were more likely to require revision surgery (17.9% vs 8.3%, p = 0.002). PFDD was associated with greater improvements in headaches (89.6% vs 80.8%, p = 0.04) and back pain (86.5% vs 59.1%, p = 0.01). There were no differences between groups for improvement in neurological examination findings. PFDD was associated with greater reduction in anteroposterior syrinx size (43.7% vs 26.9%, p = 0.0001) and syrinx length (18.9% vs 5.6%, p = 0.04) compared with PFD. CONCLUSIONS PFD was associated with reduced operative time and blood loss, shorter hospital stays, and fewer postoperative complications within 6 months. However, PFDD was associated with better symptom improvement and reduction in syrinx size and lower rates of revision decompression. The two surgeries have low intraoperative complication rates and comparable complication rates beyond 6 months.

KW - Chiari malformation

KW - Park-Reeves

KW - duraplasty

KW - posterior fossa decompression

KW - syringomyelia

UR - http://www.scopus.com/inward/record.url?scp=85133483462&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85133483462&partnerID=8YFLogxK

U2 - 10.3171/2022.2.PEDS21446

DO - 10.3171/2022.2.PEDS21446

M3 - Article

C2 - 35426814

AN - SCOPUS:85133483462

SN - 1933-0707

VL - 30

SP - 39

EP - 51

JO - Journal of Neurosurgery: Pediatrics

JF - Journal of Neurosurgery: Pediatrics

IS - 1

ER -

Complications and outcomes of posterior fossa decompression with duraplasty versus without duraplasty for pediatric patients with Chiari malformation type I and syringomyelia: a study from the Park-Reeves Syringomyelia Research Consortium

Abstract

Bibliographical note

Keywords

Publisher link

Find It

Other files and links

Fingerprint

Cite this